Stacy Wiegman, a Sharecare Editorial Advisory Board member, is a licensed pharmacist and a medical writer and editor. During her career she has managed both hospital and retail pharmacies, worked in the pharmaceutical industry as a medical science liaison in oncology and gastroenterology, served as a poison control specialist and a nursing home consultant, and taught medication error prevention seminars. Stacy is also the editor of the conception site on bellaonline.com. Education: â¢ Master of Science, Hospital Pharmacy Administration, University of Wisconsin â¢ Doctor of Pharmacy, University of Kansas â¢ Bachelor of Arts in Communication Studies with Highest Distinction, University of Kansas
Communication Studies, University of Kansas, Lawrence, Kansas
Doctor of Pharmacy, University of Kansas, Lawrence, Kansas
Hospital Pharmacy Administration, University of Wisconsin, Madison, Wisconsin
Hospital Pharmacy Administration, University of Wisconsin
Medication safety, Institute for Safe Medication Practices
Additional Certifications of Specialty Qualifications
Professional Membership or Societies
American Society of Consultant Pharmacists
Stacy Wiegman, PharmD's contact info
Address & contact info:
Tega Cay, SC 29708
Before you visit Wiegman:
Every effort has been made to ensure the accuracy of the information in this directory. However some
changes may occur between updates. Please check with your provider to ensure that he or she
participates in your health plan.
TUESDAY, April 15, 2014 (HealthDay News) -- Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.
The FDA described Tanzeum (albiglutide) as a "glucagon-like peptide-...Full Article
MONDAY, April 14, 2014 (HealthDay News) -- Boys with autism were three times more likely to have been exposed to antidepressants known as SSRIs in the womb than typically developing children, according to new research.
The new study also found that boys whose mothers took SSRIs -- drugs...Full Article
THURSDAY, April 10, 2014 (HealthDay News) -- No evidence exists to show that anti-flu medicines stockpiled by countries around the world protect people from the spread of flu or reduce related hospitalizations and complications, a new analysis contends.
WEDNESDAY, April 9, 2014 (HealthDay News) -- A long-term study suggests that older people who use common prescription painkillers, including prescription-strength ibuprofen, may be increasing their risk for developing a type of irregular heartbeat called atrial fibrillation.
THURSDAY, April 3, 2014 (HealthDay News) -- People suffering a potentially fatal narcotic overdose now can receive lifesaving treatment from folks around them, using a new device just approved by the U.S. Food and Drug Administration.
Evzio is a hand-held auto injector that delivers a sin...Full Article
THURSDAY, April 3, 2014 (HealthDay News) -- A simple urine test for people with high blood pressure could help doctors determine if patients aren't taking their medication as directed or whether their body isn't respond to treatment, a new study suggests.
WEDNESDAY, April 2, 2014 (HealthDay News) -- There's been a big increase in prescriptions for powerful narcotic painkillers given to headache patients at hospital emergency departments, a new U.S. study finds.
This increase has occurred even though guidelines from a number of medical grou...Full Article
WEDNESDAY, April 2, 2014 (HealthDay News) -- A handful of people taking a medication called Rebif to treat multiple sclerosis have developed a serious condition that causes blood clots to form in small blood vessels throughout the body.
In a letter in the March 27 issue of the New Engl...Full Article
Sharecare News posted a story about Allergy / Immunology:
WEDNESDAY, April 2, 2014 (HealthDay News) -- Just in time for the spring allergy season, the U.S. Food and Drug Administration on Wednesday approved a new under-the-tongue pill to treat hay fever caused by certain grass pollens.
Oralair is the first under-the-tongue allergen extract appr...Full Article
MONDAY, March 31, 2014 (HealthDay News) -- U.S. Food and Drug Administration approval of the drug Topamax (topiramate) to prevent migraine headaches has been expanded to include adolescents 12 years to 17 years, the agency said Friday.
It's the first migraine-prevention drug approved for ...Full Article
MONDAY, March 31, 2014 (HealthDay News) -- Although steroids are often given to patients undergoing heart bypass surgery, a large new study suggests this common practice has no benefit and could actually be harmful.
Researchers found preventive steroids do not improve the outcome of thes...Full Article